Toggle navigation
Home
Search
Services
Blog
Contact
About
Molecular Assay for Megakaryocyte Stimulating Factor
Murphy, Martin J.
Hipple Cancer Research Corporation, Dayton, OH, United States
Search 58 grants from Martin Murphy
Search grants from Hipple Cancer Research Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Assessment of sensory gating, attention, and executive control in breast cancer
TP12-1201 Hpp and Phep Cooperative Agreements
Transgenesis and Xenotransplantation
Assessment of Avoidant Personality Disorder
Mathematically Guided Experiments of Lung Mucus Transport Properties
Recently added grants:
In vivo dose finding for IN-002 in neonatal lambs for inhaled immunotherapy of RSV
Genetic Regulation of Heritable Switching in Candida albicans
Host genetic barriers to virus spillover
Impairment of B cell Responses by Pathogenic Chikungunya Viruses
Mechanistic Exploration of cGAS-STING-Mediated Vaccine Enhancement
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43DK047150-01
Application #
3496325
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1993-07-01
Project End
1993-12-31
Budget Start
1993-07-01
Budget End
1993-12-31
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Institution
Name
Hipple Cancer Research Corporation
Department
Type
DUNS #
City
Dayton
State
OH
Country
United States
Zip Code
45439
Publications
Cheng, T; Erickson-Miller, C L; Li, C et al.
(1995)
HIMeg-1, a cell line derived from a CML patient, is capable of monocytic and megakaryocytic differentiation.
Leukemia 9:1257-63
Comments
Be the first to comment on Martin Murphy's grant